ORC Expert Advisory Services ORC International

  home    |    find an expert    |    request an expert    |    join our network    |    about us     expert login  
Expert Consulting and Expert Witness Services
  
  search tips 
Share this page:  Send to LinkedIn Send to Facebook Tweet This Email Print

 Expert  724745

Expert in Due Diligence, Competitive Differentiation, Science Scouting, Innovation Assessment, Research Tools, Expert Witness, Cancer Biomarkers, Cancer Immunology, Assay Development, Research Devices


Available for your Consulting and Expert Witness Needs

California (CA)
USA
Education Work History Career AccomplishmentsPublicationsConsulting Services Expert Witness

Summary of Expertise:

Listed with other top experts in: 

Developed multiple novel immunoassays and immunology products for start-up biotechnology company. Founding Director, Research and Development for privately held company in San Diego.

Oversaw innovation and entrepreneurship at Mitchell Cancer Institute resulting in 5 spin-out biotechnology companies in the area of cancer diagnostics, cancer therapeutics, cancer biomarkers.

Served on technical advisory boards for angel investors, and State-based innovation councils. Provided due diligence reports to equity investors on research-based and clinical devices for cancer detection, diagnosis, and patient stratification.

 • 

immunoassay

 • 

due diligence

 • 

technology innovation

 • 

strategic differentiation

Expert has 15+ years' experience in the pre-clinical development use of pro-apoptotic methods for the treatment of cancer including gene therapy, cross-linking of pro-apoptotic surface molecules, and combination therapies. She holds 4 patents in this area and has been co-investigator on clinical trials using pro-apoptotic therapy for the treatment of both hematopoietic and non-hematopoietic tumors. She has also been involved in the design and implementation of biomarker studies correlating apoptotic induction and therapeutic outcome.
 • 

apoptosis

 • 

cell death

Expert has 15+ years' experience in pre-clinical development and clinical translation of therapeutics for the treatment of human cancers including lung cancer, head and neck cancers, melanoma, glioma, and non-melanoma skin cancers. Biological therapies include local, intrathecal, and systemic cytokine administration, ex vivo activation of lymphocytes, small molecules, and combination modalities. Her translational research using adenoviral p53-mediated delivery in tumors provided the groundwork for clinical trials in non-small cell lung cancer, multiple patents, and a spin-out company that became publicly traded on the NASDAQ (Introgen Therapeutics). She has collaborated in multiple Phase I, II, and III clinical trials using AdvexinTM and designed and implemented assays supporting phase I and II clinical trials (monitoring and pre-clinical development) and was an advisory board member of the Keck Gene Therapy Center at the University of Texas M.D. Anderson Cancer Center.
 • 

gene therapy

 • 

adenovirus

 • 

biological therapy

Expert has 20+ years' experience in cancer immunology, cancer biology, and cancer research spanning the areas of basic tumor biology, metastasis, apoptosis, skin cancer development, lung cancer therapeutics, gene therapy, vector payload design, cytokine biology, lymphocyte activation, antigen presentation, and immune suppression. She has been actively involved in cancer stem cell isolation and characterization, biomarker discovery for the early detection of ovarian and pancreatic cancer, and drug discovery efforts over the last decade.
 • 

cancer

 • 

cancer biology

 • 

cancer research

 • 

immunology

Expert has written INDs and served as co-investigator on a number of clinical trials for the treatment of renal cell carcinoma, glioma, melanoma, head and neck cancer, and non-small cell lung cancer. She holds 4 patents related to the induction of apoptosis for the treatment of a variety of human cancers. She has collaborated in multiple Phase I, II, and III clinical trials using AdvexinTM and designed and implemented assays supporting phase I and II clinical trials (monitoring and pre-clinical development) and was an advisory board member of the Keck Gene Therapy Center at the University of Texas M.D. Anderson Cancer Center. Expert was co-investigator on a multi-institutional PO1 grant aimed at the development of novel pro-apoptotic clinical therapies for non-small cell lung cancer. She also has experience in the design of biomarker studies for non-small cell lung cancer clinical trials.She has served as the head of translational sciences for the Mitchell Cancer Institute for the past 8 years.
 • 

translational medicine

 • 

cancer treatment

Expert is designated as a "Skin Cancer Expert" by the American Cancer Society. She has 10+ years of experience in UV-induced carcinogenesis in animal models and her work in this area has been the subject of national and international news reports.Expert has experience in animal models for primary and metastatic melanoma. In addition, she has been co-investigator on a number of clinical trials for the treatment of melanoma using biological therapy and experience with biomarker design in this therapeutic setting.
 • 

ultraviolet radiation energy

 • 

skin cancer

 • 

skin tumor


Show Secondary and Basic Areas of Expertise
Localities:
Expert may consult nationally and internationally, and is also local to the following cities: Mobile, Alabama;  Gulfport, Mississippi;  Biloxi, Mississippi;  and Pensacola, Florida.

Education:
Year   Degree   Subject   Institution  
1986   Ph.D.   Microbiology/Immunology   University of Oklahoma Health Sciences Center  
1979   B.S.   Medical Technology   University of South Alabama  

Work History:
Years   Employer   Department   Title   Responsibilities

2015 to

 

(Undisclosed Consulting Company)

 


 

Consultant

 

Provided technical advisory consulting for angel investment group, start-up biotechnology companies in cancer diagnostics and therapeutics.

Expert is self-employed at this life sciences consulting firm.

2008 to

 

(Undisclosed University)

 


 

Associate Center Director

 

Key executive leadership position responsible for strategic direction, growth and operations, financial sustainability, compliance, intellectual property development, and facilities/infrastructure supporting the Center for Basic and Translational Sciences at the institute. Chief Scientific Officer of institute responsible for research oversight, graduate training, faculty development/advancement/retention. Oversaw innovation and entrepreneurship development for Center. Provided support for the Center Director on special projects to achieve strategic objectives, policy review, problem solving, and communications to diverse external and internal stakeholders including State and local government, Federal government, Federal agencies, community thought leaders, major donors, for-profit and non-profit institutions, other academic institutions, faculty, staff, trainees, and University leadership.

At this cancer center, Expert's responsibilities fall within the bounds of Basic and Translational Sciences.

2006 to 2008

 

University of California-Riverside

 

Office of the Chancellor

 

Special Assistant to the Provost for Health Affairs and Business Development

 

Leadership position responsible for strategic planning and development, financial sustainability, and implementation of new four year medical school campus. Member of the capital, infrastructure, facilities, and work-force development planning team for a new medical school campus at UCR. Served as advisor to Chancellor and Provost Responsible for key stakeholder engagement and integration (University faculty, outside consultants, University leadership, public/private investors) Team member to evaluate institutional risk and exposure for enterprise development Led outside business development and enterprise relations for innovative funding models.

2003 to 2006

 

BioLegend

 

Research and Development

 

Founding Director, Reserach and Development

 

Key executive leadership position in biotechnology start-up company responsible for strategic planning and development of research product portfolio, development and implementation of technical services department, development of technical and marketing product materials, management of outside stakeholder relationships (business partnerships, pharmaceutical companies, Universities, thought leaders). Responsible for financial sustainability of research enterprise, talent management, compliance.

2001 to 2003

 

University of California-Riverside and City of Hope

 

Professor, Biomedical Sciences and Immunology

 

Professor

 

Led active cancer research laboratory comprised of graduate students, technical staff, postdoctoral fellows, clinical fellows, and visiting scientists. Managed NIH, ACS, and Foundation grant portfolio as principal investigator; multi-center program project grant with University of Texas M.D. Anderson, UCR, and City of Hope. Involved in clinical trials for lung cancer treatment. Taught medical students, graduate students, and undergraduate honor students. Served as thesis advisor for 5 Ph.D. students, served on multiple grant review panels, editorial boards. Invited speaker and panelist for multiple national conferences. Member of UCR Executive Committee, chair of Institutional Animal Care and Use Committee (IACUC), and member of the Biomedical Science Dean's Advisory council and the Chancellor's External Advisory committee.

1991 to 2000

 

University of Texas M.D. Anderson Cancer Center

 

Department of Immunology

 

Assistant and Associate Professor

 

Led active, large cancer research laboratory comprised of graduate students, technical staff, postdoctoral fellows, clinical fellows and visiting scientists. Managed NIH, ACS, and Foundation grant portfolio as principal investigator; multi-center program grants. Involved in clinical trials for lung cancer treatment, kidney cancer treatment, and melanoma. Taught medical students, graduate students. Served as thesis advisor for 5 Ph.D. students, on advisory committees for 65 other students, and NIH training grant faculty in Immunology and Cancer Biology. Served on multiple grant review panels, editorial boards and as member of IRB, IACUC, intellectual property committee, Keck Foundation Gene Therapy Steering Committee, and diversity committee. Invited speaker, panelist, and organizer for multiple national and international conferences. Developed intellectual property leading to the spin-out of a biotechnology company for the treatment of lung cancer, Introgen Therapeutics (became publicly traded company on NASDAQ). She collaborated in multiple Phase I, II, and III clinical trials using AdvexinTM and designed and implemented assays supporting phase I and II clinical trials (monitoring and pre-clinical development). In addition to gene therapy clinical trials, served as co-investigator on Phase I and II clinical trials involving cytokine therapy while maintaining multiple federal, private and foundation grants to support this research.

1986 to 1990

 

University of Texas M.D. Anderson Cancer Center

 

Department of Tumor Biology

 

Postdoctoral Fellow/Instructor

 

Performed basic and translational cancer research in melanoma and glioblastoma. Involved in clinical trials and new drug development. Taught graduate students and medical students.


Career Accomplishments:
Associations/Societies

American Association for Cancer Research( 1986-present) Women in Cancer Research (1990- present)

American Women in Science (AWIS) National and San Diego Chapter (2003-2006) Vice President, Gulf Coast Chapter (1997-1998)

Professional Appointments

Expert has served on the Board of Directors for the American Melanoma Society (2003-2005), the Leading Edge Institute (2010-2014), and as a member of the scientific advisory board for the University of Montana Environmental Health Sciences Institute (2001-2009). She has also served on the scientific advisory board of Signature Biosciences, Inc.(2003), and on the external advisory boards of both the University of Texas M.D. Anderson Cancer Center CML Program Project and MDS, MDS-AML studies (1999-2001) and the Burnham Institute Program Project grant (2003-present).

She currently serves on the board of Alabama Innovation Council Study Commission (Best Policies and Practices), the Alabama Science and Technology Roadmap for Life Sciences (commissioned by State Governor), the Gulf Coast Angel Network Technical Advisory Council--Biotechnology (2011-present), BioAlabama (2013-present), the Mobile Chamber of Commerce (2014-present), Innovate Mobile--Entrepreneurship (2015-present), and the American Cancer Society (2013-present).

In addition, Expert has experience on Editorial Boards including, The Journal of Experimental Therapeutics and Oncology (2000-2009), Apoptosis (1997-2004), and the Journal of Interferon and Cytokine Biology (1994-2003).

Expert has served a a grant panelist for both national and international awards including the the American Cancer Society Cancer Immunology and Leukemia, Immunology, and Blood Cells study sections (1996-2002), the Concern Foundation Grant Review Committee (2002-2003), the American Heart Association, Western States study section (2000-2001), the California Department of Health Services (1998), the National Cancer Institute Program in Molecular Immunoregulation (External Review Site Visit Team,1996), the National Institutes of Health, (Experimental Immunology, 1995), the Veterans Administration (Immunology, 1995), the National Institutes of Health Special Review Committee Site Visit Team (Burnham Institute, La Jolla, CA, 1995), Pennsylvania Department of Health-Cancer Therapeutics (2012-2014), and the M.D. Anderson Melanoma SPORE internal project review (2010-2014).

Awards/Recognition

Marquis' Who's Who in the World (2007-present) Marquis' Who's Who in Science and Engineering (2006-present) Hall of Fame Inductee, College of Allied Health/Medicine The University of South Alabama (2005) Distinguished Scientist and Outstanding Alumni Award The University of South Alabama (2004) American Cancer Society Experts Directory in Skin Cancer (2000) John McGovern Award for Outstanding Graduate Teaching The University of Texas M.D. Anderson Cancer Center (1999) Dean's Award for Excellence The University of Texas Health Science Center at Houston (1996-1997) Preuss Foundation Postdoctoral Fellowship Recipient (1986-1989) Cora M. Downs Award for Outstanding Graduate Research, American Society of Microbiology (1986) University of Oklahoma Regent's Award Outstanding Graduate Research (1985) Noble Foundation Predoctoral Fellowship (1982-1986) National Ames Graduate Scholarship in Immunology (1981)

Medical/Professional Internships

Expert served as a Preuss Foundation fellow with Dr. Elizabeth Grimm at The University of Texas M.D. Anderson Cancer Center.


Publications:
Publications and Patents Summary

Expert holds four patents in the area of cancer therapeutics and has published over 80 papers in the area of cancer biology, cancer immunology, metastasis, cancer stem cells, and apoptosis. Her scientific work has been featured on CNN news, BBC Radio, and National Public Radio and has been profiled in the Wall Street Journal, Newsweek, Time, BioWorld Today, NBC, ABC, and BBC news, among others.

Selected Publications and Publishers  
 - Cell  
 - Cancer Research  
 - Cancer Cell  
 - Science  
 - Cancer Research  

Government Experience:
Years   Agency   Role   Description
1996 to 1996   National Cancer Institute   External Site Reviewer   As a member of the External Site Review Team for the program in Molecular Immunoregulation, Expert made recommendations for future research directions and funding.
1995 to 1995   National Institutes of Health   Grant Study Section Member   As an ad hoc member of the Experimental Immunology Study Section, Expert was responsible for the review of grant proposals and recommendations for receipt of funding.
1995 to 1995   Vetrans Administration   Study Section Member   As an ad hoc member of the Immunology Grant Study Section, Expert was responsible for the review of grant proposals and recommendations for receipt of funding.
1995 to 1995   National Institutes of Health   Special Review Committee   As a member of a Special Review Committee, Expert conducted a site visit, reviewed grant proposals, and made funding recommendations for a major private research institute program project application.

Consulting Services:
Selected Consulting Examples:
  • Expert consulted with a mid-sized biopharmaceutical company on intellectual property strategy and proof-of-principle experiments necessary to advance a pre-clinical cancer therapeutic into clinical development.
  • Expert consulted with a major research University on the development of a new medical school including capital and infrastructure, research hiring and infrastructure, and core laboratory development.
  • Expert consulted with a start-up company on the development of a cancer diagnostic for ovarian cancer.
  • Expert consulted with a start-up company on clinical trial design, collection, and assay development for a cancer diagnostic for pancreatic cancer.
  • Expert consulted with equity investors on market differentiation and barriers to market entry for a novel research assay device,
Click the green button above to contact Expert for a free initial screening call regarding your expert consulting needs.  Expert is available for consulting to corporate, legal and government clients.  Remember, your initial screening call to speak with Expert is free.

Expert Witness:
Click the green button above to contact Expert for a free initial screening call regarding expert testimony, litigation consulting and support, forensic services, or any related expert witness services.  A few litigation needs include product liability, personal injury, economic loss, intellectual property (patent, trademark, trade secret, copyright), and insurance matters.  Remember, your initial screening call to speak with Expert is free.

International Experience:
Years   Country / Region   Summary
2003 to 2003   Switzerland   Swiss Cancer League Cancer grant review panel
2003 to 2003   New Zealand   New Zealand Cancer Society grant review panel
2005 to 2005   Israel   Israel Science Foundation grant panelist

Additional Skills and Services:
Other Skills and Services

Expert can provide consultation for experimental design, analysis, and interpretation of in vivo cancer and metastasis experiments as well as a variety of cancer biology experiments. Expert can provide strategic innovation consultation across a variety of areas in cancer biology and diagnostics. Expert can provide strategic guidance for immunoassay development (including sourcing of hard-to-find antibodies), trouble-shooting, and manufacture. Expert can provide strategic planning for long-range and capital infrastructure design of research facilities and core laboratories. Expert can provide strategic assessment of scientific operations in for-profit and non-profit settings. Expert can provide biomarker consultation for early cancer detection and clinical trials. Expert can plan, review, and interpret multi-parameter flow cytometric analyses. Expert can write and review grant proposals in cancer biology, immunology, cancer therapeutics, biomarkers, and apoptosis.


 

Need the right expert?  We can help!

home       find an expert       request an expert       join our network       about us

Intota is now ORC Expert Advisory Services

FOLLOW ORC ON